For research use only. Not for therapeutic Use.
Drostanolone propionate (trade name Masteron) is an anabolic/androgenic steroid which is the propionate ester of drostanolone. It is known to be androgenic and anabolic. It is incapable of aromatization and has similar properties to dihydrotestosterone. It has been successfully used as a breast cancer drug, but because of the high risk of virilization, safer options are prescribed. (Source: http://en.wikipedia.org/wiki/Drostanolone_propionate).
| Catalog Number | R065165 |
| CAS Number | 521-12-0 |
| Molecular Formula | C23H36O3 |
| Purity | ≥95% |
| Storage | -20°C |
| IUPAC Name | [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate |
| InChI | InChI=1S/C23H36O3/c1-5-21(25)26-20-9-8-17-16-7-6-15-12-19(24)14(2)13-23(15,4)18(16)10-11-22(17,20)3/h14-18,20H,5-13H2,1-4H3/t14-,15+,16+,17+,18+,20+,22+,23+/m1/s1 |
| InChIKey | NOTIQUSPUUHHEH-UXOVVSIBSA-N |
| SMILES | CCC(=O)OC1CCC2C1(CCC3C2CCC4C3(CC(C(=O)C4)C)C)C |
| Reference | </br>1:Clinical experience with dromostanolone propionate (NSC-12198) in breast carcinoma. Seay DG, Bradshaw JD, Nicol NT.Cancer Chemother Rep. 1972 Feb;56(1):89-92. No abstract available. PMID: 5067664 </br>2:[Long-term combined administration of dromostanolone propionate (Mastisol) and cyclophosphamide (Endoxan) for advanced breast cancer after surgical hormone therapy]. Nomura Y, Hattori T, Abe Y, Iguchi K.Gan No Rinsho. 1971 Dec;17(12):899-904. Japanese. No abstract available. PMID: 5172404 </br>3:[Clinical study of dromostanolone propionate for mastopathy–with special reference to screening of breast cancer]. Takeuchi S, Yoshida M.Saishin Igaku. 1967 May;22(5):1049-54. Japanese. No abstract available. PMID: 5630583 |
